Stock NUE NUEVOLUTION AB (PUBL)
Add to a list
To use this feature you must be a member
Log inSign up

Nuevolution AB (publ) Share Price

Equities

NUE

SE0007730650

Pharmaceuticals

Delayed Nasdaq Stockholm
Other stock markets
 		5-day change 1st Jan Change
- SEK -.--% Intraday chart for Nuevolution AB (publ) -0.31% +90.59%
2019 Amgen Inc. completed the acquisition of Nuevolution AB (OM:NUE) from Industrifonden, Skandinaviska Enskilda Banken AB (publ.) (OM:SEB A), Sunstone LSV Fund I K/S, SEB-Stiftelsen, Skandinaviska Enskilda Bankens Pensionsstiftelse, S-E-Bankens Utvecklingsstiftelse and others. CI
2019 Nuevolution AB Reports Earnings Results for the First Quarter Ended of March 2019 CI

Financials

Sales 2017 9.65M 1.38M 15.13M 111M Sales 2018 10.97M 1.57M 17.19M 126M Capitalization 842M 121M 1.32B 9.66B
Net income 2017 -123M -17.64M -193M -1.41B Net income 2018 -99M -14.2M -155M -1.14B EV / Sales 2017 62.2 x
Net cash position 2017 111M 15.94M 174M 1.28B Net cash position 2018 108M 15.54M 170M 1.24B EV / Sales 2018 66.9 x
P/E ratio 2017
-5.8 x
P/E ratio 2018
-7.98 x
Employees -
Yield 2017 *
-
Yield 2018
-
Free-Float 90.97%
More Fundamentals * Assessed data

Chart Nuevolution AB (publ)

Dynamic Chart

Latest news about Nuevolution AB (publ)

Amgen Inc. completed the acquisition of Nuevolution AB (OM:NUE) from Industrifonden, Skandinaviska Enskilda Banken AB (publ.) (OM:SEB A), Sunstone LSV Fund I K/S, SEB-Stiftelsen, Skandinaviska Enskilda Bankens Pensionsstiftelse, S-E-Bankens Utvecklingsstiftelse and others. CI
Nuevolution AB Reports Earnings Results for the First Quarter Ended of March 2019 CI
Amgen Inc. made an offer to acquire Nuevolution AB (OM:NUE) from Industrifonden, Skandinaviska Enskilda Banken AB (publ.) (OM:SEB A), Sunstone LSV Fund I K/S, SEB-Stiftelsen, Skandinaviska Enskilda Bankens Pensionsstiftelse, S-E-Bankens Utvecklingsstiftelse and others for SEK 1.6 billion. CI
Nuevolution's BET-BD1 Selective Inhibitor and Candidate Compound, NUE20798, Shows Positive Effect on Disease Scoring and Biomarker Levels in an Atopic Dermatitis Mouse Model CI
Nuevolution AB Announces Audited Consolidated and Parent Earnings Results for the Year Ended December 31, 2018 CI
Nuevolution AB Publ Reports Earnings Results for the Fourth Quarter Ended December 31, 2018 CI
Nuevolution AB Announces First Animal Preclinical Data CI
Nuevolution AB Announces Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018 CI
Nuevolution to Present Data from its Discovery Program Directed at Targeting the Key Disease Inflammatory Signaling Molecule, Interleukin-17A (IL-17A) CI
Nuevolution AB Announces Executive Changes CI
Nuevolution AB Announces Consolidated and Parent Earnings Results for the Second Quarter and Six Months Ended June 30, 2018 CI
Nuevolution Discloses the Identity of Its Cytokine X Program Being Interleukin IL-17A CI
Amgen Exercises Opt-In Right in First Program from Multiple Target Research Collaboration with Nuevolution CI
Nuevolution AB(OM:NUE) added to OMX Nordic Small Cap Index CI
Nuevolution AB(OM:NUE) added to OMX Nordic All-Share Index CI
More news

Press releases Nuevolution AB (publ)

Nuevolution publ : Svenska & English PU
Nuevolution publ : Svenska & Engslish PU
Nuevolution publ : AGM Proxy form UK PU
Nuevolution publ : Corporate Governance Report 2018 PU
Nuevolution publ : EDISON MARCH 2019 PU
More press releases

Company Profile

Nuevolution AB is a Sweden-based biopharmaceutical company working to develop future medicine for the treatment of cancer and inflammatory diseases. The Company’s business is conducted through its wholly owned subsidiary, Nuevolution A/S.
Sector
Pharmaceuticals
More about the company

Sector Biopharmaceuticals

1st Jan change Capi.
NUEVOLUTION AB (PUBL) Stock Nuevolution AB (publ)
+90.59% 0
CSL LIMITED Stock CSL Limited
-4.66% 86.13B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.32% 39.82B
BIOGEN INC. Stock Biogen Inc.
-19.27% 30.42B
UCB Stock UCB
+57.86% 25.23B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-16.09% 15.35B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.14% 11.95B
INCYTE CORPORATION Stock Incyte Corporation
-17.69% 11.6B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.00% 11.51B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+5.24% 8.71B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. NUE Stock